Skip to Main Content
Infectious Diseases | Men's Health | Women's Health

EPIC-P Intervention

What is the purpose of this trial?

This non-randomized, open-label study will address the following research aims in People who inject drugs (PWID):

  • To assess the feasibility and acceptability of the Expanding PrEP Implementation in Communities of PWID (EPIC-P) intervention among high-risk PWID.
  • To determine the preliminary efficacy of the EPIC-P intervention in terms of increasing adherence to PrEP and primary HIV prevention among high-risk PWID.
  • Trial with
    Gilead Sciences and Yale University School of Medicine
  • Ages
    18 years and older
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Rayne Kim

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    10/01/2024
  • Study HIC
    #2000026228